Clinical Trials

80 enrolled

Advanced HER2 Negative Breast Carcinoma HRD+Breast Cancer

NCT07011550 2026-03-11

Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer

7 enrolled

Microsatellite-stable Colorectal Cancer

NCT06385262 2026-03-06

TOP 2301: Neoadjuvant Chemo for NSCLC

126 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06860386 2026-03-06

Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC

75 enrolled

Carcinoma, Renal Cell

NCT03994796 2026-03-04

Genetic Testing in Guiding Treatment for Patients With Brain Metastases

186 enrolled

Brain Neoplasms, Neoplasm Metastasis

NCT06348147 2026-02-17

Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation

39 enrolled

Plasma cell

Multiple Myeloma

NCT07071961 2026-02-17

Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]

16 enrolled

Colorectal Neoplasms

NCT03164460 2026-02-13

Stereotactic Body Radiation Therapy or Intensity Modulated Radiation/Proton Therapy in Treating Patients With Recurrent Head and Neck Cancer

68 enrolled

Recurrent Head and Neck Carcinoma

NCT05928806 2026-02-11

ARCITECT

120 enrolled

Advanced Renal Cell Carcinoma

NCT03316573 2026-02-10

Pembrolizumab in Neoplasms or Lymphomas

18 enrolled 16 charts

LymphoidSarcoma

Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Dendritic Cell Sarcoma, Follicular, Histiocytic Sarcoma

NCT05062889 2026-02-03

ERASE-CRC

477 enrolled

Colonic Neoplasms

NCT07301268 2026-02-03

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

36 enrolled

CNSSarcoma

Astrocytoma, Glioblastoma, Gliosarcoma

NCT06254911 2026-01-27

Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma

20 enrolled

Oropharyngeal Neoplasms

NCT06575686 2026-01-21

Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma

33 enrolled

Lymphoid

Lymphoma, Follicular

NCT05183204 2025-12-18

Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma

33 enrolled

Glioblastoma

NCT06008158 2025-12-10

Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca

48 enrolled

Breast Carcinoma In Situ

NCT06112847 2025-12-10

Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma

29 enrolled

Lymphoid

Lymphoma, Follicular

NCT05955261 2025-12-09

A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia

Other hematologic neoplasm

70 enrolled

Leukemia, Myeloid, Acute

NCT05358704 2025-12-04

Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

38 enrolled

Rectal Neoplasms

NCT05405387 2025-12-03

IMPACT

Other hematologic neoplasmPlasma cell

120 enrolled

Leukemia, Plasma Cell, Multiple Myeloma

NCT03575611 2025-10-28

Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma

123 enrolled

Carcinoma, Renal Cell

NCT06855628 2025-10-28

Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM)

10 enrolled

Glioma

NCT05620771 2025-10-20

Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk

84 enrolled

Carcinoma, Hepatocellular

NCT05337735 2025-10-09

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

EndocrineGynecologicLymphoidOther solid neoplasmThoracic

140 enrolled

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Hodgkin Disease, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT05445609 2025-09-19

Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer

10 enrolled

Prostatic Neoplasms

NCT02742883 2025-09-16

A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)

1 enrolled

Diffuse Intrinsic Pontine Glioma

NCT05797870 2025-08-08

Lip-Re2

16 enrolled

Hepatocellular Carcinoma Non-resectable

NCT05591534 2025-08-01

ICUREC

31 enrolled

Rectal Neoplasms

NCT05571293 2025-07-30

NEST-1

36 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Colorectal Neoplasms

NCT06728657 2025-06-18

TORCH-G

68 enrolled

Stomach Adenocarcinoma

NCT06214793 2025-05-01

Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)

61 enrolled

Breast Neoplasms

NCT03722680 2025-04-23

RILUZOX-01

80 enrolled

Colorectal Neoplasms

NCT05375708 2025-03-28

SIRIUS

93 enrolled

Colorectal Neoplasms

NCT04840186 2024-11-12

EXCALIBUR3

62 enrolled

Colorectal Neoplasms

NCT06199882 2024-10-15

SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma

34 enrolled

Biliary Tract Carcinoma

NCT05764395 2024-10-10

Rigosertib Plus Pembrolizumab in Treating Patients With Unresectable/Metastatic Melanoma Refractory to PD-1 Inhibitors

29 enrolled

Melanoma

NCT04090463 2024-05-07

PancFORT

100 enrolled

Pancreatic Neoplasms

NCT04668768 2024-03-22

HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma

3 enrolled

Lymphoid

Lymphoma

NCT04427306 2023-09-15

Neoadjuvant T-VEC in High Risk Early Melanoma

6 enrolled

Melanoma

NCT02897050 2022-04-20

Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer

170 enrolled

Breast Neoplasms

NCT03139747 2021-10-15

UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone

5 enrolled

Thyroid Neoplasms

NCT01988831 2019-05-10

Efficacy of Propranolol Treatment to Prevent Melanoma Progression

450 enrolled

Melanoma, Recurrence

NCT03779100 2019-01-28

Lenvatinib Plus PD-1 Antibody for Unresectable ICC

25 enrolled

Cholangiocarcinoma

NCT02022293 2017-12-04

Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis

324 enrolled

Nasopharyngeal Carcinoma, Carotid Stenosis

NCT01342653 2016-11-21

HIPEC

GastrointestinalGynecologic

50 enrolled

Carcinoma, Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms

NCT01723306 2016-06-14

Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas

48 enrolled

GastrointestinalThoracic

Lung Neoplasms, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT00986284 2015-12-22

Epidermal Growth Factor Receptor (EGFR) Status Based Gefitinib Neoadjuvant Therapy in Non Small Cell Lung Cancer (NSCLC)

102 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00278122 2013-12-10

Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

42 enrolled

Melanoma

NCT01222013 2013-03-26

Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)